|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-4-26
|
|
pubmed:abstractText |
Respiratory complications continue to be a major cause of morbidity and mortality following major vascular surgery. The recent UK Small Aneurysm Trial cited preoperative respiratory function as the major predictor of outcome following elective aortic surgery.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-4804
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 Academic Press.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
81-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11319885-Animals,
pubmed-meshheading:11319885-Diaphragm,
pubmed-meshheading:11319885-Electric Stimulation,
pubmed-meshheading:11319885-Human Growth Hormone,
pubmed-meshheading:11319885-Humans,
pubmed-meshheading:11319885-Male,
pubmed-meshheading:11319885-Muscle Contraction,
pubmed-meshheading:11319885-Muscle Fatigue,
pubmed-meshheading:11319885-Rats,
pubmed-meshheading:11319885-Rats, Sprague-Dawley,
pubmed-meshheading:11319885-Recombinant Proteins,
pubmed-meshheading:11319885-Reperfusion Injury,
pubmed-meshheading:11319885-Respiration Disorders
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Preoperative treatment with recombinant human growth hormone prevents ischemia reperfusion-induced diaphragmatic dysfunction.
|
|
pubmed:affiliation |
Department of Surgery, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin, Ireland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
